[HTML][HTML] Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications

G Aurilio, A Cimadamore, R Mazzucchelli… - Cells, 2020 - mdpi.com
Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

[PDF][PDF] Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - scholarworks.indianapolis.iu.edu
Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications.

G Aurilio, A Cimadamore, R Mazzucchelli… - Cells, 2020 - europepmc.org
Abstract Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at
initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - CELLS, 2020 - air.uniud.it
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - Cells, 2020 - pubmed.ncbi.nlm.nih.gov
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

[HTML][HTML] Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - Cells, 2020 - ncbi.nlm.nih.gov
Abstract Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at
initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications.

G Aurilio, A Cimadamore, R Mazzucchelli… - Cells (2073 …, 2020 - search.ebscohost.com
Abstract Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at
initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

[PDF][PDF] Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - pdfs.semanticscholar.org
Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - 2020 - helvia.uco.es
Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

G Aurilio, A Cimadamore, R Mazzucchelli… - CELLS, 2020 - iris.univpm.it
Around 80-90% of prostate cancer (PCa) cases are dependent on androgens at initial
diagnosis; hence, androgen ablation therapy directed toward a reduction in serum …